Summary records - PDF document

1 2. Summary records
2. Summary records of the TDR Joint Coordinating Board Since 2008 * Note that all important decisions and recommendations can be found in TDRBasicDocuments. * Lists of participants are available on request fromthe TDR Secretariat.* Full meeting reports are available on the TDR web site since 2010. 2 Summary records – TDR Joint Coordinating Board Table ofContents 31st SessionRio de Janeiro, Brazil, 1618 June 2008.......................................................................32nd SessionGeneva, Switzerland, 1517 June 2009.......................................................................33rd SessionShanghai, P.R. China, 1416 June 2010.....................................................................34th SessionGeneva, Switzerland, 1315 June 2011.....................................................................35th SessionGeneva, Switzerland, 1820 June 2012.....................................................................36th SessionGeneva, Switzerland, 1718 June 2013.....................................................................* Specific RECOMMENDATIONSare displayed like this Summary records – TDR Joint Coordinating Board 3 �� &#x/MCI; 0 ;&#x/MCI; 0 ;31stSessionRio de Janeiro, Brazil, 1618 June2008 Opening session Expressed its gratitude to the Ministry of Health of the Government of Brazil for hosting JCB(31), the first session of the Board in the Americas, and thanked Professor Reinaldo Guimaraes, Secretary of Science, Technology and Strategic Health Products, Ministry of Health of Brazil, for his opening address to the Board on behalf of the Minister of Health of Brazil.Thanked Dr Elias Kavinah Sory, Director General of the Ghana Health Service, for his statement on behalf of the Minister of Health of Ghana, on the handing over of the JCB from its last session outside Geneva in Africa, in 2006, to this session in the Americas.Thanked Dr Tolulope Ibotomi Fakeye, Head, Division of Research and Statistics, Federal Ministry of Health of Nigeria, for his statement on behalf of the Minister of Health of Nigeria, supporting the efforts of Nigeria and Ghana to promote health research development in Africa and the SouthSouth Initiative on Health Research.Thanked the other officials for their statements to the Board:Dr D. Victoria, PAHO/WHO Representative in Brazil on behalf of the Director of the Pan American Health Organization/Director of the WHO Regional Office for the AmericasThe representatives of the cosponsoring agenciesUNICEF Dr Kayode Oyegbite, Senior Programme Officer, Health System and Management Unit, Health Section, Programme DivisionUNDP Mr Jeffrey O'Malley, Director, HIV/AIDS GroupWorld Bank Dr Ok Pannenborg, Senior Adviser for Health, Nutrition and PopulationWHO Dr Timothy Evans, Assistant DirectorGeneral for Information, Evidence and Research, on behalf of the DirectorGeneral of WHO. Election of ViceChair and Rapporteur Elected ProfessorRodrigo CorrêaOliveira, ViceDirector and Senior Staff Scientist, René Rachou Research Centre, Oswaldo Cruz Foundation, Belo Horizonte, as ViceChair of the JCB until its thirt

2 ysecond session in Elected Dr Jorge Mott
ysecond session in Elected Dr Jorge Motta, Director General, Gorgas Memorial Institute for Health Studies, Panama, as Rapporteur of JCB(31).Thanked Dr Frank Nyonator, Director, Policy Planning, Monitoring and Evaluation, Ghana Health Service, for his work and commitment as ViceChair of JCB over the past year.Thanked Dr Margaret Mafe, Head, Department of Health Planning, Research and Statistics, Federal Ministry of Health of Nigeria, for her work as Rapporteur of JCB(30). Report by Chair JCB Thanked Professor Rolf Korte, Senior Health Policy Advisor, German Agency for Technical Cooperation, Eschborn, for his report and work as JCB Chair over the past year and for his updates to JCB members on key issues affecting TDR. Looks forward to his continuing commitment over the coming year. Report of the Standing Committee Thanked theTDR Standing Committee members for their report and activities carried out since JCB(30) and looks forward to their further work and engagement during the coming year, based on regular review of the Programme.Welcomed the development of the frameworks ofcollaboration with the cosponsoring agencies and other partners to facilitate more substantive collaboration. 4 Summary records – TDR Joint Coordinating Board Progress and plans Thanked Dr Rob Ridley, Director TDR, the TDR Strategic Function Coordinators and Professor Peter Ndumbe, Chair STAC, for their reports to the JCB.Welcomed the start of the implementation of the new strategy from 1 January 2008 and the efforts being made to recruit the new staff required to meet the needs of the strategy.Stressed the importance of TDR's new stewardship function. Noted that its activities with other partners would help to avoid duplication, identify and fill gaps, assist with coordination and facilitate the sharing of lessons learned. Encouraged the outreach of this function to an even wider constituency.Recommended that TDR should continue to take a holistic view of research from basic and product innovation research through to implementation research and health systems, and that the stewardship function should include identification of priority areas for basic research within its objectives.Encouraged the development of milestones for the empowerment function at regular intervals over the coming 10 years (e.g. at 3, 5, 7 and 10 years) to assist in measuring success in this area.Noted the importance of efforts by TDR and JCB participants at the political level, both for strengthening of national institutions and for research at the international level.Reiterated the need for TDR to pay attention to research on the impact of climate change on tropical diseasesand on vectorborne diseases.Encouraged the integration of multidrug resistant tuberculosis issues into business lineRequested the continuous monitoring of the business lines to determine which new ones are needed and those which should be phased out, and reiterated the need for close interaction among the business lines.Emphasized the importance of TDR's comparative advantage in working closely with disease endemic countries to carry out needsdriven research.Stressed the importance of the disease endemic co

3 untries (DECs) being enabled to play a p
untries (DECs) being enabled to play a pivotal role and requested details on indicators in this important area. Welcomed input from DECs on potential indicators.Welcomed the implementation of the TDR strategy to facilitate increased participation of representatives of disease endemic countries and other regional representatives in the JCB sessions, acknowledging the need to provide support to such members to help them prepare for their participation.Encouraged collaboration with domestically funded advanced developing country research programmes, to maximize opportunities.Welcomed the current initiatives and further action to improve mechanisms for NorthSouth and SouthSouth collaboration.Stressed that TDR should be a proactive key player in new initiatives for research for health and emphasized the urgency of establishing appropriate mechanisms to ensure this involvement.Emphasized the need to increase financial support for health research by both OECD countries and disease endemic countries (DECs). Noted with pleasure the commitments by several DECs to devote 2% of their national health budget for research for health and encouraged efforts to ensure that DECs meet such commitments and that 5% of development assistance by OECD countries is invested in research.Requested TDR to develop a strategy for providing support to smaller countries.Requested that adequate attention should be paid to the needs of Eastern European countries and those in Central Asia where infectious diseases, includingmalaria and visceral leishmaniasis, are reemerging.Welcomed the efforts to collaborate with other initiatives to ensure the application of the principles of the Paris Declaration on Aid Effectiveness.Stressed the need for research to strengthen health systems, community participation, technology transfer and the longterm sustainability of efforts to control the infectious tropical diseases.Stressed the importance of research for health promoting practices, not only in relation to recent technological innovation. Summary records – TDR Joint Coordinating Board 5 �� &#x/MCI; 2 ;&#x/MCI; 2 ;33. Emphasized the importance of health economic research, which has impact with policy makers.Emphasized the need for greater linkages between researchers, policymakers and other stakeholders.Welcomed the closer collaboration with the regional offices of all the cosponsoring agencies and stressed the need for greater visibility of TDR's work in countries through the regional and country offices of its cosponsors.Reiterated the need to continue to strengthen collaboration with WHO disease control programmes and other WHO research programmes as appropriate.Stressed the importance of research to facilitate the revitalization of primary health care and health systems strengthening.Encouraged that the results of key research findings should be published in open access, peerreviewed journals, but noted with concern that journals are often unwilling to publish negative results. Technical presentations Welcomed the reinstitution of the past practice of inviting TDRsupported investigators or TDR trained scientists to give technical presentat

4 ions to the JCB which give an understand
ions to the JCB which give an understanding of the substantive nature of the work being supported by TDR.Thanked the three scientists Dr A. Schwartz Benzaken, Dr E. Elhassan, and DrJ.Barbosa da Silva fortheir excellent presentations.Noted that the discussions in reaction to these presentations, while primarily focused on specific technical details, raised the importance of more strategic thinking by the JCB on the significance of these research areas r the 10 year strategy. Specifically, the JCB felt that the multicountry study on integrated communitydirected interventions has brought about significant strategic opportunities that merit further consideration.Encouraged the TDR secretariat to developa strategy to scaleup this work, taking it to a wider scientific and policy audience and drawing on both the "stewardship" and "empowerment" dimensions of business line 11 (where the integrated communitydirected interventions study has been funded) to articulate an intensified effort to build the priority for, and capacity to undertake this sort of research with disease endemic countries playing a pivotal role. Governance and related issues Role of TDR in the future environmentIn relation to the Intergovernmental Working Group on Public Health, Innovation and Intellectual PropertyRecognized the outstanding achievement in reaching consensus on the Global Strategy on Public Health, Innovation and Intellectual Property at this year's World Health Assembly (resolution WHA61.21).Recognized the important contribution that TDR has already made to assist the realization of the Global Strategy and Plan of Action.Noted the document by Director TDR on the Programme's potential response to the Global Strategy and Plan of Action.Recognized the alignment between the Global Strategy and Plan of Action and TDR's vision and mission, but noted that the Global Strategy and Plan of Action extend beyond TDR's vision and mission.Requested consultation and coordination with WHO concerning the areas in which TDR should engage in the development of the implementation plan of the Global Strategy and Plan of Action.Recommended that TDR create and mobilize additional capacities to respond to the Global Strategy and Plan f Action, whilst protecting the Programme's mission and classical areas of activity.Urged Director TDR to develop and present to the next meeting of the Standing Committee a budgeted plan of action to meet these capacity needs, including key milestones and organizational and human resource requirements.Requested regular feedback during the year and further discussion on this issue at JCB(32). 6 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 0 ;&#x/MCI; 0 ;In relation to the Global Ministerial Forum on Research for Health: Strengthening Research for Health, Development and Equity (Bamako 2008)Encouraged the continuing active involvement of TDR in the preparations for the Bamako Forum and looks forward to receiving details of the outcomes of the Forum for which many countries have high expectations.Noted the recommendation made in the Tehran Communiqué by the Tehran High Level Preparatory Meeting for the 20

5 08 Global Ministerial Forum on Research
08 Global Ministerial Forum on Research for Health to establish 18 November as World Day of Research for Health, and expressed its support for this initiative to set up such a day.TDR governanceAgreed on the proposed transition arrangements in 20082010 concerning the establishment of constituencies under paragraph 2.2.1 of the TDR Memorandum of Understanding.Agreed on the proposed operating procedures from 2009 for JCB constituencies under paragraph 2.2.1 of the TDR Memorandum of Understanding.Considered the various options for the future composition of the TDR Joint Coordinating Board:Supported in principle a change in the composition of the JCB and the establishment of constituencies, based on the premise of increasing the representation of countries, especially the disease endemic countries.Requested the Standing Committee to provide more details concerning the definitions of nongovernmental organizations and academic institutions as outlined in options 2 and 3.Requested further work to address potential conflict of interest.Requested more information on the feasibility, mechanisms and impact of including nonhealth ministries.Indicated that emphasis should be placed on option 2 in the immediate future, and that option 3 might be better considered in the longer term.Requested further discussion on the options by the Standing Committee and presentation of more detailed proposals to JCB(32).Agreedthat the oneyear term of office for the ViceChair JCB should be maintained.Agreed:to continue the ex officioparticipation in the Standing Committee meetings of the Chair and ViceChair of the JCB, the Chair of STAC and three additional coopted JCB members, one representing the OECD group of countries and two representing the disease endemic countries (one of which should represent subSaharan Africa); andthat the Standing Committee should continue to monitor such ex officioparticipation and report to the JCB on the experience gainedAgreed that the Standing Committee should keep under review and report to the JCB on the continuing efforts to strengthen relationships among the JCB, STAC, the TDR secretariat and WHO.Agreed that the Standing Committee should keep under review any need for an administrative services agreement with WHO. Financial and communications issues Financial mattersAccepted the Opinion of the External Auditor of WHO on the financial report on the TDR Trust Fund for the 2007 biennium.Accepted the Financial Report of the TDR Programme Manager for the Biennium 2006Welcomed TDR's continuing efforts to improve timely expenditures and implementation rates.Approved the revised TDR aspirational budget for 20082009. Summary records – TDR Joint Coordinating Board 7 �� &#x/MCI; 2 ;&#x/MCI; 2 ;64. Approved the updated procedures for budget revision and for the receipt of designated funding to meet the needs of the new strategy.Encouraged donors to ensure their contributions are identified for TDR and to provide undesignated funding and multiyear pledges to the extent possible.Noted with pleasure the increasing contributions by disease endemic countries (DECs) and encouraged more DECs to identify resource

6 s to support TDR's activities.Outreach a
s to support TDR's activities.Outreach and leverage, resource mobilization, communications and advocacyAppreciated the ongoing work to develop strategic alliances, increase outreach and leverage activities, strengthen resource mobilization and communications and advocacy activities. Welcomed the rebranding of the Programme,including the development of the new TDR web site, logo and strapline.Welcomed closer links with partners, e.g. re the Global Fund to Fight AIDS, Tuberculosis and Malaria on operational research, Sida concerning donor alignment and harmonization in cooperation on research for health, the Government of Germany concerning fostering equitable and cohesive NorthSouth and SouthSouth research partnerships, and the Government of the Netherlands concerning fostering the development of a priority medicines agenda by disease endemic countries.Encouraged increased financial support to TDR to meet the needs of the aspirational budget.Noted with pleasure that JCB participants can call on the TDR secretariat as a resource to provide them with information and assist them technically where appropriate. Membership of the Scientific and Technical Advisory Committee (STAC) Endorsed the membership of STAC in 2009 and looked forward to redressing the gender imbalance in 2010. JCB Membership Selected the Governments of the United Arab Emirates and Zambia for JCB membership for four years from 2009 under paragraph 2.2.3 of the TDR Memorandum of Understanding.Noted that the Governments of Malaysia and Spain, and the new constituencies of (i)Germany and Luxembourg, and (ii) the United Kingdom of Great Britain and Northern Ireland and the United States of America had been selected by the TDR resource contributors to JCB membership for four years from January 2009 under paragraph 2.2.1 of the Memorandum of Understanding. Alsonoted that as from January 2009, the Governments of the Netherlands and Sweden would form a constituency with a term of office until 31 December 2010; and the Governments of Norway and Switzerland would form a constituency with a term of office until 31December 2009. Dates and place of JCB(32) and JCB(33) Decided that the Thirtysecond Session of the Joint Coordinating Board will take place at WHO headquarters, Geneva, from the afternoon of Monday 15 through Wednesday 17 June 2009.Supported in principle that JCB sessions should be held alternately at WHO headquarters in Geneva and in disease endemic countries. Requested the Standing Committee to consider a costeffective venue in a disease endemic country for JCB(33) in 2010. Welcomed the offers from the Government of China and from the Government of Thailand to host JCB(33). Closing session Reiterated its gratitude to the Ministry of Health of the Government of Brazil for its excellent hospitality. Thanked the staff of the Ministry, of the Oswaldo Cruz Foundation, of the PAHO/WHO Office in Brazil, the Hotel Sofitel, TDR and all other staff for their help in organizing the session and the site visits. 8 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 0 ;&#x/MCI; 0 ;32ndSessionGeneva, SwitzerlandJune2009 Regular business Commende

7 d TDR on the progress made in the implem
d TDR on the progress made in the implementation of the new strategy during the past year and accepted the reports of: Director TDR; Chair JCB; the Standing Committee and the Scientific and Technical Advisory Committee (STAC).Accepted the TDR interim financial report for 2008, financial status and budget revisions in 2008Approved a Programme budget for the 20102011 biennium of US$ 121 million. Noted that TDR aspires to the level of US$ 146 million in line with the targets agreed in the TDR Business Plan 2008Agreed that JCB(33) will take place in Shanghai, China, followed by site visits during the week of 1418 June 2010; and that JCB(34) will take place in Geneva, Switzerland, on 1416 June 2011. Strategic issues Endorsed the recommendations of STAC and the Standing Committee on TDR's proposed response to the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Requested Director TDR to move forward to the next planning phase and to present a detailed plan and budget to STAC32 and to JCB(33) in 2010.Recognized the opportunities for enhanced collaboration and synergies between WHO and Geneva based organizations focusing on research for health. Noted the 11 May 2009 meeting in Geneva on collaborative arrangements in global research for health and the steps being taken by the organizations and programmes concerned to take this issue forward. Requested TDR to actively engage in this process and to keep the JCB fully informed of developments.Agreed to set up a working group, under the cchairmanship of Chair JCB and Chair Standing Committee, to further examine the options for the future composition of the JCB and to propose a revised option for consideration by JCB(33) in 2010. Opening session, and election of Chair, ViceChair and Rapporteur Thanked the representatives of the TDR cosponsoring agencies for their opening statements to the JCB.Elected Dr Jorge Motta, Associate Investigator, Gorgas Memorial Institute for Health Studies, and Member of the National Directing Council of the National Research System, Panama, as Chair of the JCB for the coming two years.Elected Professor Rossitza KurdovaMintcheva, Head, Parasitology and Tropical Medicine Department, Centre of Infectious and Parasitic Diseases, Ministry of Health, Bulgaria, asViceChair of the JCB until its thirtythird session in 2010.Elected Sir Isi Henao Kevau, Executive Dean and Professor of Internal Medicine at the University of Papua New Guinea, as Rapporteur of JCB(32).Expressed its deep gratitude to Professor Rolf Korte, Senior Health Policy Advisor, German Agency for Technical Cooperation, for his excellent chairmanship of the JCB over the past two years and looked forward to his continuing support and commitment as the JCB representative of his Government.Thanked Professor Rodrigo CorrêaOliveira, Director, René Rachou Research Centre, Brazil, for his work and commitment as ViceChair of the JCB over the past year.Thanked Dr Jorge Motta, Panama, for his work as Rapporteur of JCB(31). Report by the Chair of the Joint Coordinating Board Thanked Professor Rolf Korte, the outgoing JCB Chair for his excellent report and accepted the report of the

8 JCB Chair. Report of the Standing Commit
JCB Chair. Report of the Standing Committee Accepted the report of the Standing Committee and thanked the TDR Standing Committee members for their activities carried out since JCB(31). Looked forward to their further work and engagement during the coming year, based on regular review of the Programme. Summary records – TDR Joint Coordinating Board 9 Report of Director, and scientific progress and plans Accepted the report of the TDR Director and commended the Programme on the progress made in the past year.General strategic mattersNoted the importance of TDR taking a holistic multisectoral approach to research on diseases of poverty, with links to poverty alleviation strategies and the Millennium Development Goals.Requested TDR to take into consideration the increasing degree of neglect of some tropical diseases.Recognized the need for political will to apply the products of research for the control and elimination of diseaseRecognized the diversity of situations within regions and within many middle income countries, which often contain pockets of poverty, and encouraged TDR to pay particular attention to the needs of worst affected communities. Reiterated the request thatadequate attention be paid to the needs, especially for capacity building and operational research, of Eastern European countries, the Caucasus and those countries in Asia where parasitic diseases, including malaria and visceral leishmaniasis, are reemerging.Welcomed TDR's exploration of opportunities to leverage bilateral support to countries for research.Looked forward to receiving frameworks for collaboration with the cosponsoring agencies and other appropriate partners.Matters related to leadership, visibility and indicatorsEncouraged TDR to move beyond its stewardship function to take on a leadership role in global health research for diseases of poverty.emphasized the importance of the disease endemic countries (DECs) being enabled to play a pivotal role, and stressed the need for the rapid development of indicators, in collaboration with the DECs, for this important area.emphasized the need for greater visibility of the Programme at regional and country level through the regional and country offices of all the TDR cosponsoring agencies, including through the WHO Regional Committee meetings as indicated below.Encouraged TDR to better capitalize on its strong research and capacity building outputs when compared to many other organizations, despite its limited resources.Encouraged TDR to explore opportunities to link with regional research organizations operating beyond the health sector, notably in science and technology.Encouraged TDR to explore ways of utilizing its meetings held outside Genevato link with decisionmakers.Requested TDR to provide JCB participants with interim updates on progress between JCB sessions.Matters related to TDR strategic and technical functionsEncouraged that more emphasis be placed on the reporting of outcomes by the Stewardship and Empowerment strategic functions, rather than reporting on process. Requested TDR to explore ways, in collaboration with other partners, to assist DECs to develop capacity to set their own

9 national research agendas and prioritie
national research agendas and priorities.Requested TDR to explore ways to assist DECs in accessing resources for research from other funding agencies.In the area of Empowerment, encouraged TDR to strengthen the capacity of research institutions in addition to individuals.Reiterated the need for TDR to develop a strategy for providing support to strengthen research capabilities in smaller, low income countries. 10 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 2 ;&#x/MCI; 2 ;38. Emphasized the value of SouthSouth collaboration and working with and through other partnerships and networks, e.g. the African Network for Drugs and Diagnostics Innovation, and the value of engagement with the private sector in the DECs.Recognizing that the gap between research and policy is often wide, encouraged TDR to provide more information on mechanisms and best practices to transfer research outcomes into policy and practice.Urged TDR to continue to provide support for basic research, particularly through the promotion of partnerships and networks.Urged TDR to continue to provide support for operational research activities.Noted with concern the reports of artemisinin resistance, recognizing that the appropriate use of rectal artesunate should not contribute to the development of such resistance.Requested TDR to consider the integration into existing business lines of activities currently outside business lines.Matters related to the Scientific and Technical Advisory Committee (STAC)Accepted the report of STAC and looked forward to receiving information on the implementation of its recommendations by TDR. Thankedthe Chair and members of STAC for their hard work over the past year, including their participation in the additional subgroup meeting in May 2009.Expressed appreciation of the transparency of the documentation provided by STAC and its constructive critical advice, scientific review and assessment of TDR. Looked forward to receiving feedback from STAC on TDR's organizational and managerial processes to ensure the effective use of resources, maximizing collaboration and leverage both within and outside WHO.Requested STAC to consider whether (i) emerging tropical diseases should be included in the TDR research portfolio, and (ii) research to assist elimination strategies should be included more centrally within the portfolio.Matters related to WHO, including WHO Regional OfficesWelcomed the closer collaboration between TDR and the WHO Regional Offices and encouraged further efforts to strengthen this collaboration. Noted the appreciation and value of the small grants programme in most of the Regions and the desire to extend the programme also to the African Region.Noted with pleasure the regular item on the agenda of the annual meeting of the WHO Regional Committee for SouthEast Asia concerning feedback from the JCB session to the Regional Committee andencouraged other Regional Committees to consider the adoption of this practice. Encouraged the participation of representatives of the JCB and senior TDR staff in such Regional Committee meetings.Welcomed the ongoing efforts to enhance technical collab

10 oration with the WHO disease control pro
oration with the WHO disease control programmes but recognized that more needs to be done. Encouraged the participation of representatives of such WHO programmes in the sessions of the Joint Coordinating Board and similar participation by TDR staff at key review meetings of the control programmes.Encouraged TDR, where appropriate, to take advantage of the use of WHO collaborating centres.Matters related to financingRecognized that with the current critical economic and financial environment, there is a need for strict prioritization and the demonstration of progress and impact based on highlevel indicators.Notwithstanding this economic and financial environment, requested TDR to maintain a balance of longterm, mediumterm and shortterm research activities.Requested TDR to ensure that it only accepts funding for new activities which are aligned with the Programme's strategy and Business Plan.Encouraged TDR to explore opportunities for cofunding of activities with countries and noted in particular e opportunities to do this with middle income countries. Summary records – TDR Joint Coordinating Board 11 Technical presentations Welcomed the continuation of the practice of inviting TDRsupported investigators or TDR trained scientists to give technical presentations to the JCB which provide an understanding of the substantive nature of the work being supported by TDR.Thanked the two scientists Dr Rasheda Samad, Assistant Professor of Paediatrics, Chittagong Medical College and Hospital, Bangladesh; and Dr Wellington Oyibo, Associate Professor, Department of Medical Microbiology and Parasitology, University of Lagos, Nigeria for their excellent presentations. New related international initiatives: role and implications for TDR Endorsed the recommendations of STAC and the Standing Committee onTDR's proposed response to the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. Requested Director TDR to move forward to the next planning phase and to present a detailed plan and budget to STAC32 and to JCB(33)in 2010. Noted that the shortterm costs for the development of the plan are limited.Welcomed the complementarity and synergies which exist between the draft WHO strategy on research for health and the TDR strategy, and the opportunities presented by such synergies.Noted the opportunities presented during the development of the World Health Report on research in 2012, to work with many organizations globally in order to produce a strong document to advocate on research for health.Recognized the opportunities for enhanced collaboration and synergies between WHO and Geneva based organizations focusing on research for health. Noted the 11 May 2009 meeting in Geneva on collaborative arrangements in global research for health and the steps being taken by the organizations and programmes concerned to take this issue forward. Requested TDR to actively engage in this process and to keep the JCB fully informed of developments. Governance Transition arrangements under paragraph 2.2.1of the TDR Memorandum of Understanding Agreed to continue the exceptional transition arrangements towards constituencies

11 under paragraph 2.2.1 of the TDR Memoran
under paragraph 2.2.1 of the TDR Memorandum of Understanding (MOU) in 2009 and 2010.Composition of the JCBThanked the Standing Committee for the document submittingproposals for the future composition of the JCB, based on the preferred option and other requests from JCB(31) in 2008.In light of the fact that JCB participants had a variety of views on the proposed option, agreed to set up a working group (details of the membership and terms of reference are shown in Annex 1) to examine these views in detail, in collaboration with the Standing Committee and to propose a revised option for consideration by JCB(33) in 2010.Other issues raised by JCB(31)Agreed:To the proposed revision of the ex officioJCB representation at the Standing Committee meetings: to be covered by just the Chair and ViceChair of the JCB, and the Chair of STAC, with the proviso that:additional members will be coopted on an ad hocbasis if needed for (a) particular meeting(s);at least two participants from disease endemic countries are present at each Standing Committee meetingefforts should be made to avoid major gender imbalance.That the Standing Committee keeps under review and reports to the JCB annually on the continuing efforts to strengthen relationships among the JCB, STAC, the TDR Secretariat and WHO. should be understood that members of the Standing Committee may only represent the views of their respective organizations 12 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 2 ;&#x/MCI; 2 ;o That the Standing Committee keeps under review and reports to the JCB annually on whether there is a need for a specific documented administrative services agreement within the context of WHO acting as the Executing Agency for TDRThat the Standing Committee should monitor any potential implications of WHO policies on TDR, such as the new partnership policy, and bring them to the attention of the JCB. Financial and communications issues Accepted the Interim Financial Report of the TDR Programme Manager for2008 and Financial Status Welcomed TDR's continuing efforts towards timely expenditures and good implementation rates.Approved the budget revisions in 2008Requested the TDR secretariat to continue its careful management of financial resources and adjustments of the budget in line with available resources.Approved a Programme budget for the 20102011 bienniumof US$ 121 million and requested clarification of the end products associated with this budget level in a revised budget document.Noted that TDR aspires to a Programme budget for the biennium at the level of US$146 million in line with the targets in the approved TDR Business Plan 2008Appreciated the ongoing work to develop strategic alliances, increase outreach and leverage activities, strengthen resource mobilization and communications and advocacy activities. Welcomed the rebranding of the Programme, including the new TDR web site, logo and strapline.Looked forward to receiving the new resource mobilization strategy.Encouraged all JCB participants to redouble their efforts to raise funds for TDR, including the disease endemic countrie

12 s, despite the financial crisis.Encourag
s, despite the financial crisis.Encouraged donors to ensure that their contributions are identified for TDR and to provide undesignated funding and multiyear pledges to the extent possible. Membership of the Scientific and Technical Advisory Committee (STAC) Endorsed the proposed membership of STAC as of 1 January 2010. Update on TDR engagement in special initiatives Welcomed the update on the fiveinitiatives and TDR's engagement in them. Expressed the hope that the benefits of these initiatives will reach all countries around the world which need their assistance. JCB membership from 2010 Noted the selections made by the TDR resource contributors for JCB membership for four years from 2010 under paragraph 2.2.1 of the Memorandum of Understanding:the Government of Brazilthe new constituency of the Governments of Ghana and Nigeriathe new constituency of the Governments of India and Thailandthe continuing constituency of the Governments of Norway and Switzerland.Selected two Governments for JCB membership forfour years from 2010 under paragraph 2.2.3 of the TDR Memorandum of Understanding:Iran (Islamic Republic of)Japan The Bamako Global Ministerial Forum on Research for Health; the Berlin stakeholders meeting on strengthening research partnershipsfor neglected diseases of poverty; ESSENCE on Health Research Enhancing Support for Strengthening the Effectiveness of National Capacity Effort; the Positive Synergies Project research at the interface between global health initiatives and health systems; and The Yaoundé Process strengthening health innovation in Africa. Summary records – TDR Joint Coordinating Board 13 Date and place of JCB(33) and JCB(34) Recommended that the Thirtythird Session of the Joint Coordinating Board take place in Shanghai, China, during the week of 1418 June 2010, with two and a half days for the JCB, to be followed by site visits to institutions which carry out collaborative activities with TDR.Decided to hold the Thirtyfourth session of the Board at WHO headquarters, Geneva, Switzerland, from Tuesday 14 June to Thursday morning 16 June 2011. Closing session Thanked Director TDR and his staff, and all other staff involved, for their help and support to the JCB(32) session. Annex 1 Governance Working GroupMembers:Open to JCB members and Standing Committee, and other Cooperating Parties as may be coopted by the ChairsChairs: Chair of JCB and Chair of Standing CommitteeTerms of Reference: The Working Group will:Develop a revised option for the future composition of the JCB under paragraph 2.2.3 of the TDR Memorandum of Understanding and address other governance issues, including paragraph 2.2.1Make a detailed recommendation on paragraph 2.2.3Develop broad principles for other governance issuesAs a basis ofits work, consider the views expressed by the JCB in respect of TDR's future governanceProvide regular information/updates to, and opportunities for comments from, JCB members which are not participating in the Working Group, as well as JCB observersReport to JCB(33) in 2010 33rdSessionShanghai, P.R. China, 1416 June 2010 Introduction The Thirtythird sessi

13 on of the Joint Coordinating Board (JCB)
on of the Joint Coordinating Board (JCB) of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), was hosted by the Government of the People's Republic of China. It was the first JCB session to be held in the WHO Western Pacific Region. The session was organized with the support and close collaboration of the National Institute of Parasitic Diseases (NIPD), which is part of the Chinese Center for Disease Control and Prevention (China CDC), the Shanghai Municipal Bureau of Health and the WHO China Office. JCB(33) was honoured by the presence at the opening session of Dr Chen Zhu, Minister of Health of the People's Republic of China and DrShin Youngsoo, WHO Regional Director for the Western Pacific.JCB(33) was preceded by an International Symposium on Research and Control of Infectious Diseases of Poverty, which was organized by NIPD in collaboration with TDR and took place in Shanghai on 13 June 2010. Many JCB participants took part in this event, some as speakers, session moderators and panellists. The Symposium marked the 60th anniversary of the NIPD and the institute's 30th anniversary as a WHO Collaborating Centre for malaria, schistosomiasis and filariasis. JCB participants at the Symposium witnessed the signing of a Memorandum of Understanding (MOU) between China CDC and TDR, which put an emphasis on collaboration in Africa. 14 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 0 ;&#x/MCI; 0 ;Following the two and half day session of JCB(33), participants were invited to take part in optional site visits to Chinese research institutions in Shanghai, Wuxi and Nanjing, with which TDR has been closely collaborating for many years. A TDR training course was in progress at the Jiangsu Institute of Parasitic Diseases in Wuxi during the JCB visit. Summary ofdecisions and key recommendations JCB(33) recommended that TDR:Enhances its visibility and ensures that cosponsoring agencies give due recognition to TDR contributions when reporting to their governing bodies and stakeholders.b.Reinvigorates its relationship and cooperation with its cosponsors and develops, when and where appropriate, mutually beneficial plans of operation with concrete budget and time lines. Actively pursues, in line with its 10 year strategy and with the support of its cosponsors, a functional decentralization by proactively involving DECs on the ground as partners of its activities.d.Seeks to promote and partner the establishment of new networks and strengthen its linkages with existing research networks in disease endemic countries (DECs) at national and regional level.Engages with and seeks support from ministries of science and technology and other relevant ministries, as well as ministries of health, in promoting its vision and strategy.Further develops its strategies to supportthe development of research capacity particularly in low income countries.g.Continues to support career development for young investigators within an institutional development framework.h.Be more explicit in its contribution to the achievement of MillenniumDevelopment Goals (MDGs), particularly t

14 he health related MDGs 4, 5 and 6, and b
he health related MDGs 4, 5 and 6, and be more specific on the outcome and impact of its activities.Maintains clarity in its direction, taking into account national health plans and WHO policies at regional level.Explores convening high level meeting(s) to advocate for increased investments in research priorities identified for infectious diseases of poverty.k.Advocates for and assists countries to make resources available for research in line with international commitments and obligations and supports the development of research systems and priority setting mechanisms.Introduces, in the context of its performance assessment framework, incentives for staff to strive for continuous quality improvement to be supportedby documented evidence that can be audited at regular intervals. m.Defines clear objectives and criteria for JCB membership of nongovernmental entities under paragraph 2.2.3 of the TDR Memorandum of Understanding to be presented for endorsement to JCB(34)n.Presents its expenditure with more detail by region, income level of countries and level of fund designation.JCB(33) reminded TDR resource contributors that, given WHO’s new policy on partnerships, funds must be specified for TDR when making contributions to WHO.JCB(33) endorsed the establishment of a TDR alumni network for advocacy and engagement in local policy making.JCB(33) gave its endorsement to:TDR's Performance Assessment FrameworkPlans for the TDR interim external reviewProposed wayforward on TDR governance (membership of the JCB) Summary records – TDR Joint Coordinating Board 15 �� &#x/MCI; 2 ;&#x/MCI; 2 ;• Resource Mobilization StrategyCommunications StrategyMembership of the Scientific and Technical Advisory CommitteeJCB(33) accepted the following reports:Report of the Chair JCBReport of the Standing CommitteeReport of the Director, TDRReport of the Chair, Scientific and Technical Advisory CommitteeReport of the Strategic Alliance Advisory Group (SAAG)Financial Report34thSessionGeneva, Switzerland, 1315 June 2011 Introduction The Thirtyfourthsession of the Joint Coordinating Board (JCB) of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) took place at WHO headquarters in Geneva. The Session was attended by all JCB members except for Congo and Indonesia who sent their apologies. Several governments and organizations also attended the session as observers.JCB(34) took place shortly after TDR went through a major reorganization. The key points of discussion and decisionmaking concerned TDR's financial situation and the planning of its activities and budget for the biennium Summary of decisions and key recommendations Statutory business Dr Sue Kinn, United Kingdom, was elected Chair of JCB for a period of two years, DrModest Mulenga, Zambia, was elected ViceChair of JCB for one year and DrMariaTeresa Bejarano, Sweden, Rapporteur for the Thirtyfourth Session.The agenda of the Thirtyfourth Session of the JCB was adopted.The report of the Thirtythird Session of the JCB was approved. Acceptance and approval of reports The report of the outgoing Chair JCB was accepted.The

15 report of the Standing Committee was acc
report of the Standing Committee was accepted.The report of the Chair of the TDR Scientific and Technical Advisory Committee (STAC) was approved.The report of the Director TDR was approved. JCB membership The application from Panama and Spain to form a constituency from 1 January 2012 was accepted. Panama will join Spain for the remainder of Spain's term until 31December 2012.The application from Japan for the vacancy created by Panama under paragraph 2.2.1 of the TDR Memorandum of Understanding (MoU) from 1January 2012 until 31 December 2014 (the remainder of Panama's term), was accepted. The application for membership from the Drugs for Neglected Diseases initiative(DND) to fill the vacancy created by Japan under paragraph 2.2.3 from 1 January 2012 until 31December 2013 (the remainder of Japan's term), was accepted. TDR was encouraged to promote further applications from nongovernmental CooperatingParties when other vacancies arise under paragraph 2.2.3. 16 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 0 ;&#x/MCI; 0 ;The JCB agreed that:It is expected that all members represented on the JCB under paragraph 2.2.1 contribute financial resources to the Special Programme on an annual basis, and preferably on the basis of a multiyear commitments and before the annual sessions of the JCB.Where possible, the JCB shall consider the allocation ofat least three seats on the JCB under paragraph 2.2.3 of the MoU to nongovernmental Cooperating Parties; andThe Chair of JCB, the Chair of the TDR Scientific and Technical Advisory Committee and a representative designated by the members on the JCB under paragraph 2.2.1 shall continue to participate on an exofficio basis in the meetings of the Standing Committee. Gustavo Kourí Memorial Lecture The proposal to organize a Gustavo Kourí Memorial Lecture at the annual sessions of the JCB was welcomed. The JCB requested that the concept be further elaborated by the TDR secretariat, taking into account that these lectures may be offered to a wider audience than the JCB. TDR reorganization and future direction The JCB commended the speed of the Programme's reorganization and the support provided by the Standing Committee and Scientific and Technical Advisory Committee. The JCB stressed the importance of maintaining high quality science in the context of existing financial constraints and not losing important information during the reorganization process.Recommendations made included the following:STAC (or a "mini STAC") shouldmeet before the end of 2011 to further discuss TDR's planned activities for the 20122013 biennium, ideally as soon as the new Director TDR takes office. STAC should liaise on issues pertaining to TDR's strategic direction, policies and activities with the JCB, possibly through a JCB subgroup.STAC should not only evaluate scientific and technical aspects of TDR's programmes and projects but also their cost effectiveness.A subcommittee of the JCB may work with STAC to look at policy issues related to TDR's portfolio of activities.Short and frequent informal reports from the TDR secretariat to the JCB are encouraged to facilitate increase

16 d transparency.The Thirtyfifth Session o
d transparency.The Thirtyfifth Session of the JCB should include an agenda item on how best TDR cosponsors can meettheir roles and responsibilities as set forth in the MoU and support TDR.In documentation associated with the Programme's reorganization and revised strategy, better definition and clarity is required on the core business and comparative advantages of TDR, e.g.through mapping of TDR's activities against other organizations, funding agencies and current funding trends, and the management of crosscutting issues both within TDR and with partners. TDR's financial situation and resource mobilization The JCB took note of the financial report and budget for the biennium 20122013 and requested further budgetary information and a detailed examination by the Standing Committee.The JCB recommended that financial information should be presented by activities and technical results.The JCB requested that the TDR Secretariat should develop financial scenarios to be examined and discussed by the Standing Committee. The JCB cautioned against a scenario which would foresee TDR taking a loan of several million dollars to remedy its current financial situation and requested TDR to seek further curbing of its expenditure.The JCB recommended a twopronged approach to resource mobilization: in the short term, to address 2011 funding requirements and in the medium to long term, to ensure full funding of the budget level approved by the JCB.The JCB recommended that financial information should be presented in correlation with technical results. Summary records – TDR Joint Coordinating Board 17 �� &#x/MCI; 2 ;&#x/MCI; 2 ;19. The JCB stressed the importance for TDR to further step up its fundraising activities, targeting potential new sources of funding as well as seeking additional funding from longstanding TDR partner countries that are emerging economies, while at the same time ensuring existing support from key donors.The JCB considered it to beimportant that TDR claim its share of the credit for the success of certain programmes such as the African Programme for Onchocerciasis Control (APOC), and to highlight the uniqueness and significance of its contribution. Projects and activities The JCB recommended that TDR should:make special efforts to inform, highlight and promote its projects/partnerships/networks at relevant multilateral meetings, e.g. promotion of the African Network for Drugs and Diagnostic Innovation (ANDI) at the Annual Conference of Ministers of Finance, Planning and Economic Development organized by the UN Economic Commission for Africa.consolidate progress with ANDI before expansion of the concept to other continents. ensure ways of reaching and supporting countries across all regions with special continuing needs and special topics associated with them (e.g. vivax malaria, leishmaniasis).ensure that the balance between its stewardship and empowerment activities is maintained and continue to provide support to institutions within the framework of stewardship and empowerment.actively assume the lead in promoting and implementing research priorities emerging from the Global Report on Infectious

17 Diseases of Poverty (IDEA report).takef
Diseases of Poverty (IDEA report).takeforward the establishment of a regional training centre in Africa.proactively engage and better communicate with Francophone, Lusophone and Hispanic disease endemic countries and give priority to forging new partnerships in such countries.continue its commitment to further promote an integrated approach to malaria interventions.offer training in grant writing.continue the small grants programme which has the potential to bring in low cost technologies and interventions with a huge impact. TDR Interim External Review The JCB recommended that the interim external review be brought forward to be initiated in 2011 to assist in future planning. Several donors underlined the importance of the outcome of the midterm review for their future funding decisions. Appointment of the new Director TDR The JCB requested to be represented on the selection panel for the new Director TDR with two representatives.The JCB underlined that for the post of Director TDR, both excellent leadership and management skills, as well as high scientific credibility based on a solid track record, will be required. Membership of STAC The JCB approved the proposed appointment of six new members of STAC who were selected following a competitive process of applications and who will replace, as of 1 January 2012, the six members of STAC whose membership will come to an end on 31 December 2011. Date and venue of the Thirtyfifth Session of the JCB JCB(35) will take place in Geneva from 18 to 20 June 2012. JCB(36) is tentatively scheduled to take place from 19 June 2013, either in Geneva or possible in a country of the Middle East. Following the JCB session, nominations for JCB members were requested and an electronic vote organized to select two representatives from the four nominations received. 18 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 0 ;&#x/MCI; 0 ;35th SessionGeneva, Switzerland, 1June 2012 Introduction The Thirtyfifth Session of the Joint Coordinating Board (JCB) of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) took place at WHO headquarters in Geneva from 18 to 20 June 2012. The session was chaired by Dr Sue Kinn from the United Kingdom and attended by all JCB members except Brazil, Côte d’Ivoire, Portugal and the UnitedArabEmirates who sent their apologies. Representatives of several governments and organizations also attended the session as observers (see Annex 2).The deliberations of JCB(35) focused on TDR’s new strategy 20122017, TDR’sachievements since JCB(34) and the Programme Budget and work plan for the Biennium 20122013. Important decisions taken included the adoption of TDR’s new strategy and measures to further strengthen TDR governance.Summary of proceedings Opening session In her opening remarks, Dr Sue Kinn, welcomed the JCB members and observers. She extended a warm welcome to Dr John Reeder, the new Director of TDR. She also extended a special welcome to the Drugs for Neglected Diseases initiative (DNDi) which joined the JCB in January 2012 as

18 the first nongovernmental member since
the first nongovernmental member since the Rockefeller Foundation’s membership on the JCB ended in 1981, and to Dr Mario Henry RodriguezLopez, Chair of the TDR Scientific and Technical Advisory Committee (STAC), who played an important role in TDR’s strategic reorientation.Dr Hiroki Nakatani, WHO Assistant DirectorGeneral for HIV/AIDS, TB, Malaria and Neglected Tropical Diseases, welcomed the delegates on behalf of WHO and conveyed special greetings from Dr Margaret Chan, DirectorGeneral of WHO. Dr Nakatani paid tribute to TDR’s rich history of achievements, which includes development of tools and strategies that lie at the heart of efforts to eliminate diseases such as leprosy, Chagas' disease, lymphatic filariasis and onchocerciasis (African river blindness) and the provision of evidence for policies and approaches now used to control a number of infectious diseases, including malaria, dengue and visceral leishmaniasis. He underlined the importance of this Board meeting, which comes at a time when TDR looks forward to guidance and support from the JCB in moving forward.Dr John Reeder, Director TDR, conveyed his commitment and motivation to lead TDR through a challenging period, expressing confidence that TDR is emerging reinvigorated, and thanking the JCB for its continued support and guidance. Statutory business Election of the Chair and Vice Chair The Chair JCB expressed her appreciation and thanks for the support she received from the ViceChair JCB, Dr Modest Mulenga from Zambia. Dr Kinn also extended her thanks to the outgoing Rapporteur, Dr MariaTeresa Bejarano from Sweden, for her support and excellent work.Dr Modest Mulenga from Zambia was elected as ViceChair JCB for a second term of one year.Dr Ignace Ronse from Belgium was elected as Rapporteur for JCB(35).Approval of the Report of JCB(34)The Report of JCB(34) was circulated to the members of the JCB in July 2011.The JCB(34) report was approved.Future JCB reports will be sent to JCB representatives for electronic approval within two weeks of the meeting. There will be no need to table the report again for approval at the next JCB.Adoption of the AgendaThe Draft Agenda of JCB(35) was circulated to the JCB members and observers in March 2012 and the Draft Annotated Agenda was made available on the JCB SharePoint site a month before the meeting.The Agenda for JCB(35) was approved. Summary records – TDR Joint Coordinating Board 19 Report by the Chair of the Joint Coordinating Board The Chair JCB briefly recalled some of the main recommendations made by JCB(34) and commended TDR for the followup action taken.A key highlight happened the day after JCB(34) closed when TDR was awarded the 2011 Gates Award for Global Health at a ceremony in Washington DC. This is a great achievement and recognition of TDR's worover its 35 year history. In July 2011, Chair JCB wrote a letter to the TDR cosponsors and launched an appeal with TDR’s donors for additional funding. Three key donors of TDR Japan, Sweden and the United Kingdom provided TDR with special additional financial resources. At the end of August 2011, Dr Robert Ridley left TDR to become the Pr

19 o Vice Chancellor of the University of M
o Vice Chancellor of the University of Malawi. Dr MariePaule Kieny, WHO Assistant DirectorGeneral for Innovation, Information, Evidence and Research and TDR Special Programme Coordinator, took up the position of adinterim Director of TDR until the new Director, Dr John Reeder, took office in February 2012.In November 2011, the Chair and ViceChair JCB attended, exofficio, the meeting of the Standing Committee in Berlin. They also participated in the deliberations of the Standing Committee in Washington DC in February 2012. The Chair and Vice Chair also actively participated in a number of Standing Committee consultations by teleconference. In December 2011, the JCB received and approved electronically, a revised Programme Budget for the Biennium 20122013. This marked an important milestone in TDR’s reorganization process.The report of the Chair JCB was accepted. Report of the Standing Committee The TDR Standing Committee (SC) recommended that TDR should refocus its activities in two areas where the Programme has comparative advantages and is recognized to be a key global player: (i)implementation research in close partnership with disease control programmes; and (ii) capacity building in disease endemic countries for health research on infectious diseases of poverty.The SC welcomed the presentation made in Washington by the new Director TDR shortly after taking office and endorsed the strategic directions that he outlined. The SC recommended including the following as key guiding principles during the strategy development process: value for money, quality, equity and innovation.The SC discussed extensively the issue of TDR governance and recommended that action should be taken to enhance accountability and to clarify the role and function of the TDR governing bodies and, in particular, decisionmaking processes. The SC recommended that all TDR project proposals should be submitted on the basis of full cost recovery (TDR recently introduced this policy). The SC recommended a TDR Programme Budget for the Biennium 20122013 of US$ 60 million and a further reduction of staff to 30 from its current staff of 58.The report of the Standing Committee was accepted Report by the Chair of the Scientific and Technical Advisory Committee (STAC) The Chair of STAC, Professor Mario Henry RodriguezLopez, highlighted the role STAC played in the review of TDR’s portfolio of activities, the Programme Budget 20122013 and the strategy setting process. As Chair of STAC, he participated in the deliberations of the Standing Committee and chaired a meeting of a subgroup of the STAC that took place in November 2011, as well as the 2012 annual meeting of STAC which took place in April STAC provided useful guidance in the elaboration of TDR’s new strategy and gave its endorsement to the strategic orientations. STAC also advised on the resultsbased approach to priority setting and budget allocation. Feedback was provided on how tobest utilize TDR’s existing networks and on linking with WHO disease control programmes to strengthen collaboration in addressing priorities.The report of the STAC was accepted. 20 Summary records – TDR Joint Coord

20 inating Board Programme Review Fo
inating Board Programme Review Followup to the JCB(34) decisions and recommendationsTDR has kept update a detailed table with actions taken in response to the decisions and recommendations from JCB(34). Examples from the table were presented.A TDR risk management framework is under development, addressing risks associated with financial, portfolio and project management.Interim External ReviewThe scope and quality of the analysis provided by the Interim External Review was welcomed by the JCB. The Review has been particularly useful for the future strategic orientations of TDR and for the review of TDR’s governance. Actions have been taken to address the key recommendations. Operational and financial performanceTDR has now put into place the recommendation to stop subsidizing designated funding (DF) projects using core funding (UD)and is currently renegotiating donor agreements to include full staff costs wherever possible. TDR presented the Results Reportfor the second year. The presentation was appreciated by the JCB and is regarded as a useful reporting tool.Designated funding is deposited and managed in separate accounts.TDR should differentiate clearly between designated and undesignated (core) funding for budget planning and reportingDesignated funding should be listed by project.The TDR 2011 Results Report was endorsedRecommendationThe Performance Assessment Framework needs to be updated, adjusting expected results and targets to the outcomes of the new strategy and workplan, ensuring measures for outcomes of publications, training courses and networks are included. Programme Budget 20122013 and future strategic direction Future strategic direction and reorganizationThe presentation of the new strategy by Director TDR generated a lot of positive feedback. The JCB commended the focus on health impact and the crosssectoral approach.The JCB welcomed the proposed new working model, which focuses more on facilitation and coordination than direct implementation by TDR staff. The JCB encouraged TDR to further step up its collaboration with countries, partners (including cosponsors) and networks.There was a consensus that the JCB should not micromanage TDR’s reprofiling process, which will follow WHO’s rules and regulations and should leave TDR with the required skillset to implement its new strategy. However, the JCB reaffirmed that the reorganization should be carried out within the approved budget framework (which foresees a TDR staff ceiling of 30 people). JCB approved TDR’s new strategy which focuses on intervention and implementation research, research capacity strengthening and knowledge management.RecommendationJCB advised that ethics networks, research management strengthening and advocacy for global and regional policies should be covered under research capacity strengthening and networks. Summary records – TDR Joint Coordinating Board 21 �� &#x/MCI; 0 ;&#x/MCI; 0 ;Workplan and Programme Budget for the biennium 20122013 and outlook for the biennium 2014At its meeting in October 2011, the Standing Committee reviewed various budget scenarios and recommended a budget

21 ceiling of US$ 60 million based on a sta
ceiling of US$ 60 million based on a staff count of 30. In December 2011 this budget was approved, following electronic consultation by the JCB.The JCB responded positively to the fact that for the first time the TDR budget is based entirely on expected results and each expected result is costed.TheJCB recognized the fact that STAC has looked not only at the technical aspects but has also provided guidance in allocating budgets for expected results.JCB authorizes TDR to accept designated funding beyond the current budget ceiling for 20122013, providing that the following three criteria are met. The designated funding:supports the achievement of outcomes included in the TDR strategy.fully covers the cost of activities and staff, thereby requiring no crosssubsidy from core resources (undesignated funds).is monitored in separate accounts.Any designated funding beyond the approved ceiling which does not meet the above criteria, for example because it requires coinvestment of core resources, shall only be accepted by TDR following consideration of the Standing Committee and a decision by the JCB.JCB reconfirmed its approval of the 20122013 biennium Programme Budget of US$million, originally approved in December 2011.RecommendationsA conservative approach should continue to be used when forecasting income.In the future TDR should develop budget scenarios in order to be able to adjust the budget, if necessary, to the actual income received. Future Programme Budgets should contain a clear differentiation for each budget line between designated and undesignated funding.TDR cosponsors are encouraged to financially support joint activities with TDR (e.g.TDR/UNICEF implementation research).TDR should give priority to supporting research activities that are part of disease endemic countries’ comprehensive national health plans.The budget line for coordination should be deleted and integrated into the budget lines for output. Summary of recommendations and decisions of day 1 The decisions and recommendations of day 1 were summarized anddiscussed at the beginning of day 2. Review of TDR governance Following JCB(34) and the recommendations of the Interim External Review, a JCB Working Group on Governance was created to consider options for increasing the effectiveness of TDR governance. Options were presented fordecreasing the membership of the JCB under paragraph 2.2.2 of the MOU;b.prolonging the term of office of the Chair and Vice Chair JCB; andcreating a JCB sub group with delegated power of authority from the JCB to take decisions on matters requiring attention in between the annual sessions of the JCB, and to facilitate decisionmaking by the JCB.Two options were also presented for reforming the Standing Committee:to discontinue the ex officio participation in the Standing Committee and focus its deliberations in particular on matters related to the cosponsorship of the Programme; and 22 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 3 ;&#x/MCI; 3 ;b.to continue the current practice but enlarge the participation in the Standing Committee and make it more representative.The JCB supported a reduc

22 tion of membership of the JCB under para
tion of membership of the JCB under paragraph 2.2.2 of the MOU, but pointed out that this should not affect the important role that developing countries play in the governance of TDR, but rather constitute a stimulus to form informal constituencies or applyfor JCB membership as resource contributors.There was broad agreement around the expectation that JCB members should more closely engage in the governance process by nominating representatives who could stay in contact with the secretariat throughout their term of membership, including in between the annual JCB sessions.The proposal to extend the term of office of the Chair JCB from 2 to 3 years and for the ViceChair JCB from 1 to 2 years was welcomed for ensuring continuity and strengthening the effectiveness of their important function and role.Following a rich discussion, the JCB opted for strengthening the current practice in respect of the Standing Committee meetings, including by providing the Standing Committee with Standard Operating Procedures (SOPs). The JCB decided not to create a JCB subgroup, but agreed with the possibility to establish, on a temporary basis, task related ad hoc committees if and when required, to deliberate on particular issues and/or prepare for JCB decisionmakingJCB decided to reduce its membership under paragraph 2.2.2 of the Memorandum of Understanding (MoU) from twelve to six members (one per WHO region). Informal constituencies could be formed under paragraph 2.2.2 to allow further countries to be represented on the JCB, but funding support to participate in the JCB will be limited to one representative per region.The term of office of the Chair of the JCB is extended from 2 to 3 yearsand the ViceChair from 1 to years. The Standing Committee will systematically expand its deliberations beyond the four cosponsors of TDR to include exofficio participation of the Chair and the ViceChair of the JCB, one representative of the JCB resource contributors group, one representative of the DEC group and the chair of STAC. The representatives of the resource contributors group and DECs will be nominated by the JCB.The Standing Committee will develop its own standard operating procedures (SOPs), for review by WHO Legal Counsel and submission to the JCB for its approval. The SOPs should include the expanded ex officio participation in the Standing Committee’s deliberations.The representative of Belgium was nominated as the representative of the JCB resource contributor group and the representative of Djiboutiwas nominated as the representative from the JCB DEC group in the expanded Standing Committee deliberations.RecommendationJCB recommended that members give clear terms of reference to their representatives in order to allow them to perform effectively on the JCB. Resource Mobilization and Communications Strategy The fundraising environment remains challenging, however there are potential new opportunities for TDR to mobilize resources with an increased focus on achieving the Millennium Development Goals,the focus on climate and environmental change, strengthening health systems and evidencebased delivery of health programmes. Programme efficiency and ef

23 fectiveness are important for donor fund
fectiveness are important for donor funding decisions. Donors pay more attention today to transactioncosts, impact assessments, evaluations and reporting on results achieved. The TDR Performance Assessment Framework is a key tool in this regard and should demonstrate the value and comparative advantage of undesignated funding.The JCB commended the continued strong commitment of key donors and encouraged all JCB members to find ways of supporting TDR in their countries and regions. Director TDR intends to promote TDR’s new strategy with existing and potential new donors. Summary records – TDR Joint Coordinating Board 23 �� &#x/MCI; 2 ;&#x/MCI; 2 ;47. Disease endemic countries are encouraged to duly acknowledge the research support provided by TDR and to recognize the importance of their partnership with TDR.TDR’s recognized convening power and reputation for high quality research should be promoted as key comparative advantages of theProgramme.RecommendationsTDR core contributors should harmonize their reporting requirements and accept TDR’s reporting through the JCB.Director TDR should engage in a high level dialogue with the Global Fund to Fight AIDS, Tuberculosis and Malaria to explore collaboration aimed at promoting evidencebased sustainable interventions.TDR should further strengthen its collaboration with WHO’s disease control programmes. Technical presentation Dr Sodiomon Sirima, Director of the National Malaria Research and Training Center in Burkina Faso gave a presentation on TDRled implementation research for better control of pneumonia and malaria at community level in Burkina Faso. JCB members noted the collaborative approach between the centre, TDR and other stakeholders and emphasized the need to link such research projects to national health programmes in countries to foster long term sustainability. Global Report for Infectious Diseases of Poverty Professor David Molyneux from the Liverpool School of Tropical Medicine highlighted key issues from the Global Report, underlining the substantive body of knowledge reflected in the report which should find its way to practical application. The JCB commendedthe scope of the report and TDR for its role in facilitating its publication, bringing together different sets of expertise. The report merits wide dissemination. Selection of JCB members Results of the election of four members under Paragraph 2.2.1 of the TDR Memorandum of UnderstandingJCB reelected for membership from 1 January 2013 until 31 December 2016 the constituencies of:(1) Germany and Luxembourg(2) Panama and Spain(3) United Kingdom of Great Britain and Northern Ireland and the United StatesJCB elected as a new member from 1 January 2013 until 31 December 2016:(4) TurkeySelection of two members of the JCB according to Paragraph 2.2.3 of the TDR Memorandum of UnderstandingJCB reelected for membership from 1 January 2013 until 31 December (1) ZambiaJCB elected as a new member from 1 January 2013 until 31 December 2016:(2) Burkina Faso Membership of the Scientific and Technical Advisory Committee (STAC) JCB discussed the options proposed by the JCB Working Gr

24 oup on Governance, considering also the
oup on Governance, considering also the input received from Chair STAC. A smaller STAC was considered to enhance its effectiveness and to be in line with the reduction of TDR staff.JCB recognized, however, that STAC may require coopting external experts and recommended this to be done within the approved budget. JCB decided to reduce the STAC membership from 21 to 15 members with the possibility for the Chair to coopt experts on an ad hoc basis when and if needed and within the budget allocated to STAC. 24 Summary records – TDR Joint Coordinating Board Review of TDR key achievements since JCB(34) and outlook 2012 JCB commended the Director TDR for his presentation which was considered useful for the donors and for fundraising.JCB advised TDR to give more visibility to donors of undesignated (core) funds when reporting on its achievements. Summary of decisions and recommendations The Rapporteur presented the decisions and key recommendations of JCB(35) which were noted with thanks by the Board. Closing session Dr MariePaule Kieny, ADG/IER, expressed her appreciation and thanks for the continued commitment demonstrated at this meeting by the JCB participants towards the Special Programme.The Chair of JCB thanked the participants and TDR staff who all contributed to the success of this annual session of the Board.JCB(36) will take place in Geneva from 1719 June 2013.RecommendationConsideration should be given to reducing the duration of the JCB meeting to 2 full days.36th SessionGeneva, Switzerland, 1June 2013 Introduction The Thirtysixth Session of the Joint Coordinating Board (JCB) of the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) took place at WHO headquarters in Geneva on 17 and 18 June 2013. The session was chaired by Dr Sue Kinn from the United Kingdom and attended by all JCB members except Brazil, Iran, Turkey, UNDP and the World Bank who sent their apologies. Representatives of several governments and organizations also attended the session as observers (see Annex 2). The deliberations of JCB(36) focused on reviewing TDR’s achievements since JCB(35) and the Programme Budget and workplan for the 20142015 biennium. Important decisions taken included the adoption of TDR’s biennial budget, approval of revisions to the TDR Memorandum of Understanding and endorsement of the 2013 Revision of TDR’s Performance Assessment Framework.Summary of proceedings Opening session In her opening remarks, Dr Sue Kinn, Chair of the Board, welcomed JCB members and observers. DrKinn mentioned that some members had not been able to attend for various reasons.Dr Hiroki Nakatani, WHO Assistant DirectorGeneral for HIV/AIDS, TB, Malaria and Neglected Tropical Diseases (HTM), welcomed the delegates on behalf of WHO and conveyed special greetings from Dr Margaret Chan, DirectorGeneral of WHO. Dr Nakatani outlined the benefits to both TDR and the disease control departments of TDR joining the HTM cluster, through working synergistically and by systematically bringing innovation and evidence to the forefront of the decisionmaking process. Dr John Reeder, Director of the Special

25 Programme, introduced the reinvigorated
Programme, introduced the reinvigorated TDR as a stronger and more efficient Programme that will require continued support and commitment from itsBoard to lead the global agenda in research on infectious diseases of poverty. Dr Reeder remembered Meinrad Studer and Peter Ndumbe, two personalities who left a lasting mark on TDR’s development, who sadly passed away since JCB(35). The JCB held a minutes silence in their memory. Summary records – TDR Joint Coordinating Board 25 Statutory business Election of the Vice Chair and RapporteurThe Chair JCB expressed her appreciation and thanks for the support she received from the outgoing ViceChair JCB, Dr Modest Mulenga from Zambia. Dr Kinn also extended her thanks to the outgoing Rapporteur, Dr Ignace Ronse, for his support and excellent work. Dr Bocar Amadou Kouyate from Burkina Faso was elected ViceChair JCB.Dr Detlef Böcking from Germany was elected Rapporteur for JCB(36).Adoption of the AgendaThe Draft Agenda of JCB(36) was circulated to JCB members and observers and the Draft Annotated Agenda was made available on the JCB SharePoint site a month before the meeting.The Agenda for JCB(36) was adopted. Report by the Chair of the Joint Coordinating Board The year since JCB(35) was challenging with the second restructuring taking place. However, TDR staff worked with professionalism to deliver important outputs, which led to the emergence of a stronger and more focused Programme.JCB expressed their gratitude to the TDR staff members for their work.The Chair of JCB thanked the members of the Board as well as the Standing Committee for their valuable contributions.It was mentioned that due to a travel conflict the current Chair of the Standing Committee, UNDP, was unable to attend the meeting and provide a report; the summary of recommendations of the two Standing Committee meetings held since JCB(35) are available on the JCB SharePoint site.The report of the Chair JCB was accepted. Report of the Standing committee JCB welcomed the report of the Standing Committee and the summary and recommendations documents of the two meetings that took place since JCB(35). Report by the Chair, TDR Scientific and Technical Advisory Committee (STAC) The Chair of STAC, Professor Mario Henry RodriguezLopez, highlighted the role STAC played in the review of TDR’s portfolio of activities, the Programme Budget and workplan for 20142015 and the creation of ad hoc advisory committees. As Chair of STAC, Professor RodriguezLopez participated in the Standing Committee meetings and chaired the 2013 annual meeting of STAC which took place in March.Some STAC contributions that were outlined: recommendations for TDR’s operations budget and workplan for 20142015; feedback onhow to best utilize TDR’s alumni and existing networks, and on linking with WHO disease control programmes and national health programmes; recommendations on using the Strategic Development Fund; and the recommendation to keep the aspirational target related to gender equity at 50% and develop mechanisms to improve in this direction. The report by the Chair STAC was accepted. Update from TDR cosponsors The represent

26 ative of UNICEF highlighted their commit
ative of UNICEF highlighted their commitment to partner with TDR in the context of the pos2015 agenda. Priorities for potential collaboration in the field include reducing the underfive mortality rate as well as the equity agenda, where TDR research can provide particularly important evidence through innovation and by monitoring implementation of interventions. The representative of WHO mentioned that in the global development agenda post2015, health indicators must remain at the core of the discussion. In its latest World Health Report, WHO highlights the importance of health research as an essential tool to improve health in countries. 26 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 2 ;&#x/MCI; 2 ;• Followup to the report of the Consultative Expert Working Group (CEWG) on Research and Development: Financing and Coordination: the World Health Assembly (WHA) in May 2013 adopted resolution WHA66.23 that contains a mandate to review existing mechanisms to assess their suitability to perform the coordination function of health R&D and to explore and evaluate existing mechanisms for contributions to health R&D. Draft working paper 3 on Financing Mechanisms for Health R&D, preparedby the WHO Department of Public Health, Innovation and Intellectual Property, identifies a number of existing mechanisms that could be suitable starting points to coordinate and fund health R&D.JCB to consider proposing TDR as a preferred technical coordination and funding mechanism for health R&D within CEWG followup actions.Discussion pointsThere was agreement in principle among JCB members that based on its global outreach and experience, TDR has the potential to play a significant role in a new funding mechanism, including its technical aspects that will establish priorities in neglected diseases of poverty.In the interest of time and external deadlines, a thorough analysis leading to swift decisionmaking by the Standing Committee and ultimately by the JCB will be required.JCB agreed to establish a subcommittee of JCB members to consider possible TDR engagement in the followup of the Report of the Consultative Expert Working Group (CEWG) on Research and Development: Financing and CoordinationThe Secretariat should prepare a concept note for the subcommittee's consideration, including an analysis of its impact on TDR operations.The subcommittee will make recommendations of possible options by the time of the next Standing Committee meetingin October 2013. The Standing Committee will make recommendations to the JCB for final discussion and consideration.Points to consider are: the special programme status of TDR should not be affected; the initiative should be backed by reliable resources and management capacities. TDR governance The following three documents were presented to JCB: i. proposed revision to the Memorandum of Understanding; ii. Terms of Reference for Joint Coordinating Board members; and iii. Standard Operating Procedures for the Standing Committee operations. Discussion pointsThere was a shared view among members that the Terms of Reference should clearly outline that JCB takes responsibility for

27 its decisions, and that this accountabi
its decisions, and that this accountability aspect should be made more visible in the document.The communication between the Standing Committee and the JCB between meetings should be included in the Standing Committee SOPs.JCB approved the proposed revision of the TDR Memorandum of Understanding.JCB requested that TORs for JCB members and the SOPs of Standing Committee be revised based on comments from the JCB and circulated electronically for approval by the JCB before the end of July JCB TORs should include reference to accountability for the decisionmaking. SOPs of the Standing Committee should include reference to communication between JCB and the Standing Committee, electronic consultation and approval process. TDR should submit a proposal on how to reduce the workload of organizing JCB meetings and communicating with JCB members and observers between meetings. Summary records – TDR Joint Coordinating Board 27 TDR progress since JCB(35) Director TDR thanked the donors who contributed during the past year. Donors have shown strong commitment to TDR, which has enabled the Programme to continue to deliver and make advances on its 2017 strategic plan.TDR successfully completed its reorganization in 2012. The new strategy is well received and successful transition towards full implementation is under way. Implementation of the financial recovery plan is well under way. The reorganization has led to a more efficient structure, which means that in 20142015 double the current amount will be used for operations direct funding, and around 85% of the budget will be spent on projects (including technical staff costs).TDR’s work with WHO disease control programmes has improved significantly through regular discussions, lunchtime seminars and feedback.A framework for collaboration with WHO regions is in place, including conference calls every two months, discussing activity plans and new ways of supporting regional priorities in health research.Implementation of expected results has been progressing and the proportion of those delayed has been continuously decreasing. The projects related to TDR’s previous strategy are being transitioned out while still generating important outputs in the form of new tools, strategies and evidence for policy and practice. TDR has piloted measuring the leverage on a sample of projects and the conclusion is that each dollar TDR has invested in direct operations has leveraged an additional 2.5 dollars.TDR has implemented a risk management system (training, policy and tools) that has identified potential risks at Programme level. An action plan is also in place to mitigate risks andturn them into opportunities.Discussion pointsTDR was commended for the reorganization and for its quick turnaround time towards implementing the new strategy. Some donors reemphasized their commitment to funding TDR. TDR was encouraged to continue supporting SouthSouth collaborations by funding existing networks and addressing crosssectoral and transdisciplinary approaches that can support lowincome country interventions.Concerns were expressed regarding potential language barriers for nonEnglishspeaking gra

28 nt applicants, and for the low proportio
nt applicants, and for the low proportion of women in TDR advisory committees and among grantees.TDR Director's report was endorsed.RecommendationJCB recommended increasing the focus on gender equity by enlisting more women on advisory ommittees and by training a higher proportion of women researchers. Financial matters Financial report for 2012 and financial situation as at 1 May 2013The 20122013 bienniumhas been a transition period for TDR. The portfolio has been adapted as per the strategy within financial constraints; the financial recovery plan implementation is well under way.The 20142015 biennium will see the full speed implementation of TDR’s newstrategy, supported by efficient use of funds and a new working model.TDR has developed an internal policy ensuring that designated funds are managed in separate accounts and are fully paying for their projects, including staff time and overhead costs, therefore they do not run on the back of TDR core funding.JCB endorsed the financial report as presented.JCB requested that the Secretariat explore ways to audit implementation of the funds in the field at institution level and to present a plan at JCB(37). 28 Summary records – TDR Joint Coordinating Board �� &#x/MCI; 0 ;&#x/MCI; 0 ;TDR external audit2012 was the first year that WHO was fully IPSAS compliant, which involved changes in standards and processes that are now applied across WHO, including TDR.WHO is being audited externally each year and TDR is being audited as part of WHO external audit. WHO’s Financial Report and Audited Financial Statements are presented to the World Health Assembly every year and include TDR as a consolidated entity. In line with the common practice for all other special programmes and partnerships hosted by WHO, TDR could also satisfy itself with the WHO external audit as a means of control. TDR financial statements would then be certified by the WHO Comptroller with financial figures crosschecked with the WHO audit report.JCB decided to accept WHO external audits in place of TDR external audits.Resource mobilizationDiscussion pointsTDR core contributors have shown continuous support to TDR. There will be a process by which TDR will attempt to reengage with government donors who stopped funding during the last five years.The 20142015 income forecast is conservative and includes only funding probabilities of at least 80% based on information from donors and on historical funding levels. TDR expects funding to remain at the same level as in 2012It was mentioned by JCB members that financial contributions to TDR from cosponsors would send a welcome signal about their strong and continuing support to TDR. The outcome of the discussion between sponsors on this issue should be circulated to the JCB electronically before the end of this year. Programme performance TDR’s Performance Assessment Framework has been revised to reflect the Strategic Plan 20122017 and to include new ways of assessing performance such as: measuring leverage,openaccess publications and the outcome of training activities.Important aspects to strengthen TDR governance and management have b

29 een implemented, such as: working as

een implemented, such as: working as “One TDR”, joining the HTM cluster, developing a business case for TDR, a new resultschain developed with DFID and the World Bank input, a new system for risk management, and implementation of the financial recovery plan.As outlined in the 2012 TDR Results Report, expected results continued to be achieved in the past year in the area of new knowledge and innovative tools and strategies, as well as capacity strengthening initiatives.The risk management system has been implemented. The new policy and processes have led to the identification of areas of potential risk at the Programme level, for which mitigation measures have been defined and are being implemented. At project level, each new project needs to have risk assessment conducted before it can be initiated.Discussion pointsJCB commended TDR for delivering important outputs througha difficult year and praised the commitment shown by the Secretariat.Most of the delays in implementing expected results were linked to capacity building activities, as there was a limited amount of undesignated funds available as per the financial recovery plan.The JCB encouraged the Secretariat to proceed with implementing the proposed new alumni tracking system to measure the career impact of TDR training on past grantees, as well as their contribution to public health.JCB accepted the 2012 TDR Results Report and the Risk Management Plan.JCB endorsed the 2013 Revision of the Performance Assessment Framework. Summary records – TDR Joint Coordinating Board 29 �� &#x/MCI; 0 ;&#x/MCI; 0 ;RecommendationThe Secretariat needs to anticipate the potential impact that current WHO review of special programmes and partnerships may have on TDR's budget and technical focus. This assessment of risk should be done jointly with other special programmes and partnerships (for example the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction HRP). Programme budget and workplan 2014 As per JCB(35) recommendations, the 20142015 Programme Budget includes two scenarios. The US$million budget is based on a level of funding similar to the current biennium. The contingency budget of US$ 50 million takes into account possible negative changes into the funding environment. TDR will start with implementing the US$ 50 million scenario as the biennium begins, and move to the higher implementation level if forecast shows that the US$ 60 million income level will be reached. Both scenarios have been reviewed by STAC and endorsed by the Standing Committee.With operations support costs relatively similar between the two budget scenarios, any funding coming in above the US$ 50 million level will go directly to operations. US$ 37.8 million is planned to be invested in direct operations in 20142015 as part of the US$ 60 million budget scenario.Within the agreed budget, a Strategic Development Fund is proposed to be established to respond to new and arising needs and opportunities during the course of the biennium. This idea has been strongly supported by the Standing Committee and recommended by ST

30 AC.Discussion pointsJCB encouraged TDR t
AC.Discussion pointsJCB encouraged TDR to continue conducting the prioritization and harmonization of expected results in collaboration with WHO’s disease control programmes.It was emphasized that the design of the expected results has been driven by strategic priorities and plans are based on core funding. For expected results where designated funding can be identified to complement the core funding, this will be done in such a way that it will not influence TDR’s priorities.JCB members advised the Secretariat to consider further outsourcing some management responsibilities for capacity strengthening and research projects to external partners, in line with the new working model.JCB endorsed the 20142015 Programme Budget.RecommendationsThe Secretariat should develop standard operating procedures for prioritization and selection of projectsand areas of activity. Technical presentation Dr BeNazir Ahmed, from the Ministry of Health of Bangladesh, presented the results of successful interaction between implementation research and policy adoption and adaptation as part of the National Visceral Leishmaniasis Programme in Bangladesh, TDR being one of the most important funders of research projects in this area. JCB members noted the sustained collaboration over decades between TDR and health institutions in Bangladesh. Over time, this has allowed new and innovative knowledge and tools (such as new medicines and strategies) to be developed, tested and applied into policy and practice, significantly reducing mortality and morbidity due to visceral leishmaniasis. Membership of the Scientific and Technical Advisory Committee (STAC) JCB endorsed the proposed STAC membership.RecommendationThe Secretariat should develop standard operating procedures for prioritization and selection of projects and areas of activity by STAC and special advisory groups. 30 Summary records – TDR Joint Coordinating Board Selection of JCB members from 1 January 2014 to 31 December 2017 Results of the election of four members under Paragraph 2.2.1 of the TDR Memorandum of Understanding Elections JCB reelected for membership constituencies of the Governments of:(1) Ghana and Nigeria(2) India and Thailand(3) Norway and SwitzerlandJCB elected for membership the Government of:(4) MalaysiaSelection of two members of the JCB according to Paragraph 2.2.3 of the TDR Memorandum of Understanding Elections JCB reelected for membership:(1) Drugs for Neglected Diseases initiativeJCB elected as a new member:(2) Armenia Closing session Dr Mohammed Jama, Assistant DirectorGeneral of the General Management Cluster, expressed his appreciation and thanks for the continued commitment demonstrated at this meeting by the JCB participants towards the Special Programme.Director, TDR, thanked the JCB members for their support and contribution to the success of TDR.The Chair of JCB thanked the participants and TDR staff who all contributed to the success of this annual session of the Board.JCB(37) will take place in Geneva from 2325 June 2014.JCB(38) will take place in Geneva from 2224 June 2015. Summary of decisions and recommendations DecisionsDr Bocar Amadou Kouyate f

31 rom Burkina Faso was elected ViceChair J
rom Burkina Faso was elected ViceChair JCB.Dr Detlef Böcking from Germany was elected Rapporteur for JCB(36).The Agenda for JCB(36) was adopted.The report of the Chair JCB was accepted.The report by the Chair STAC was accepted.JCB agreed to establish a subcommittee of JCB members to follow up with possible TDR engagement in the Report of the Consultative Expert Working Group.The Secretariat should prepare a concept note for the subcommittee's consideration, including an analysis of its impact on TDR operations The subcommittee will consult with the full JCB and make recommendations of possible options to the Standing Committee. Points to consider are: the special programme status of TDR should not be affected; the initiative should be backed by reliable resources and management capacities. Summary records – TDR Joint Coordinating Board 31 �� &#x/MCI; 2 ;&#x/MCI; 2 ;10. JCB approved the proposed revision of the TDR Memorandum of Understanding.JCB requested that TORs for JCB members and the SOPs of Standing Committee be revised based on comments from the JCB and circulated electronically for approval by the JCB before theend of July JCB TORs should include reference to accountability for the decisionmaking. SOPs of the Standing Committee should include reference to communication between JCB and the Standing Committee, electronic consultation and approval process. TDR should submit a proposal on how to reduce the workload of organizing JCB meetings and communicating with JCB members and observers between meetings.TDR Director's report was endorsed.JCB endorsed the financial report as presented.JCB requested that the Secretariat explore ways to audit implementation of the funds in the field at institution level and to present a plan at JCB(37).JCB decided to accept WHO external audits in place of TDR external audits.JCB accepted the 2012 TDR Results Report and the Risk Management Plan.JCB endorsed the 2013 Revision of the Performance Assessment Framework.JCB endorsed the 20142015 Programme Budget.JCB endorsed the proposed STAC membership.JCB(37) will take place in Geneva from 2325 June 201JCB(38) will take place in Geneva from 2224 June 2015.RecommendationsJCB recommended increasing the focus on gender equity by enlisting more women on advisory committees and by training a higher proportion of women researchers.The Secretariat needs to anticipate the potential impact that current WHO review of special programmes and partnerships may have on TDR's budget and technical focus. This assessment of risk should be done jointly with other special programmes and partnerships (for example HRP).The Secretariat should develop standard operating procedures for prioritization and selection of projects and areas of activity by STAC and special advisory groups.ElectionsJCB reelected for membership under paragraph 2.2.1 of the MOU the constituencies of the Governments of:(1) Ghana and Nigeria(2) India and Thailand(3) Norway and SwitzerlandJCB elected for membership the Government of:(4) MalaysiaJCB reelected for membership under paragraph 2.2.3 of the MOU:(1) Drugs for Neglected Diseases initiativeJCB elected as a new